{"name":"Cellbion Co., Ltd.","slug":"cellbion-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFB5b2lyU1lkc3Zvb1RLM3J0RV8tclFMaEdtSWN4ZTExMmtwczlJOFQ1RzVBd3hhSVdPXzJ1T0lTVWdLSHhTV1ZKdWZ3REVPMG9JXzdseTgwUm9EaWpvMExtd0o0d1hPbzJIYm9nTlU0Q01PaThERlhV?oc=5","date":"2025-09-28","type":"pipeline","source":"KED Global","summary":"Korean pharmaceuticals, another victim of Trump tariffs - KED Global","headline":"Korean pharmaceuticals, another victim of Trump tariffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5LWVhULVVUQjFnY3pxNXBIdVBNZXFjcWhCRnZpVWNFa2d0Y2dtV1plWnhoSUdWYVppbEdmdm4wYzR0M2ZQZk9FbkNKTEJTdmxvb0JkVklLOFZPSWhfSV9mOEJySXNNOEpPM2NhY1dB0gFyQVVfeXFMUFFyUXJ1Y3J4Z1U2MU51RUZnSGlHQkE2TXdYUnhMV3dqLWkybm9ReXd6YlpWTjB0aEFSS2pydE1fTVJaMC1sTHowR3JjRGM3aFgyMG9TaGVtYlQwb1JNY001NElJMVVpXzl5UktubmJNQlZn?oc=5","date":"2025-02-05","type":"trial","source":"koreabiomed.com","summary":"MSD and CellBion launch Korea’s 1st radioligand-immunotherapy trial for prostate cancer - koreabiomed.com","headline":"MSD and CellBion launch Korea’s 1st radioligand-immunotherapy trial for prostate cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBINGstN1FmbjRqcGlHMmdBUzI4Ry1zTEQ0SjBmQ1d1MHVOamZSNkx3bzY5TUFRc09RWlNQc2dQX1d1QUpiR2xHUWpjV2FLc0N4Y192UjBYSngzRTVJQVk0R2RaZk5mZDBMRjhvVTl30gFyQVVfeXFMT2ptMzJPZWx4QXVjR2ZJaTVxT0NGX2lxSldwSDU1X3JzRV81c0tfcWdMZlJtaThZQWJvbHVnaUNJcU5tM3JXOGt1RXNBSmxfb1l1ZFRWV3lsOUd3RF9rc2RsUTloUElDZmlNQ2JROXV5ejlB?oc=5","date":"2025-01-14","type":"pipeline","source":"koreabiomed.com","summary":"Korea’s radiopharmaceutical market heats up as companies vie for global leadership - koreabiomed.com","headline":"Korea’s radiopharmaceutical market heats up as companies vie for global leadership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQTU1XRUJYZUpRTjhobkhIekZJdk1OeUVidDQxY1E5ZHpqdWtoWjV4bUJQbWE3ZlQ1NVlCUXlTbnJPeDVVTWRVVmx2RmozN0M4RTFvSHZxcU1LU3kyVXUzYmJ3SWxjZXlWR3c0T3YwN21QZUt6Y3FkNFJnU2pNMjBHTGhwemg0S0hzNUNkY1NjLVVfYlRaVU1melNLLW1adXFveW1SV3JuLVFKcnRQb0tua2xBWUFuLXZLNW1kXw?oc=5","date":"2025-01-09","type":"pipeline","source":"BioWorld News","summary":"Biopharma IPOs rebound slightly, as class of 2024 lags with a 29% average decline - BioWorld News","headline":"Biopharma IPOs rebound slightly, as class of 2024 lags with a 29% average decline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}